<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Parry EM</submitter><funding>NHGRI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>158-169</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10155825</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(1)</volume><pubmed_abstract>Richter syndrome (RS) arising from chronic lymphocytic leukemia (CLL) exemplifies an aggressive malignancy that develops from an indolent neoplasm. To decipher the genetics underlying this transformation, we computationally deconvoluted admixtures of CLL and RS cells from 52 patients with RS, evaluating paired CLL-RS whole-exome sequencing data. We discovered RS-specific somatic driver mutations (including IRF2BP2, SRSF1, B2M, DNMT3A and CCND3), recurrent copy-number alterations beyond del(9p21)(CDKN2A/B), whole-genome duplication and chromothripsis, which were confirmed in 45 independent RS cases and in an external set of RS whole genomes. Through unsupervised clustering, clonally related RS was largely distinct from diffuse large B cell lymphoma. We distinguished pathways that were dysre</pubmed_abstract><journal>Nature medicine</journal><pubmed_title>Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.</pubmed_title><pmcid>PMC10155825</pmcid><funding_grant_id>K08 CA270085</funding_grant_id><funding_grant_id>R21 CA267527</funding_grant_id><funding_grant_id>P30 CA015083</funding_grant_id><funding_grant_id>R50 CA251956</funding_grant_id><funding_grant_id>U10 CA180861</funding_grant_id><funding_grant_id>R01 CA236361</funding_grant_id><funding_grant_id>P01 CA206978</funding_grant_id><funding_grant_id>T32 HG002295</funding_grant_id><funding_grant_id>R01 CA213442</funding_grant_id><pubmed_authors>Deng S</pubmed_authors><pubmed_authors>Hess J</pubmed_authors><pubmed_authors>Lin Z</pubmed_authors><pubmed_authors>Elagina L</pubmed_authors><pubmed_authors>Parikh SA</pubmed_authors><pubmed_authors>Livak KJ</pubmed_authors><pubmed_authors>Broseus J</pubmed_authors><pubmed_authors>Stewart C</pubmed_authors><pubmed_authors>Ruthen N</pubmed_authors><pubmed_authors>Livitz D</pubmed_authors><pubmed_authors>Slowik K</pubmed_authors><pubmed_authors>Jain N</pubmed_authors><pubmed_authors>Kipps TJ</pubmed_authors><pubmed_authors>Purroy N</pubmed_authors><pubmed_authors>Cymbalista F</pubmed_authors><pubmed_authors>Levovitz C</pubmed_authors><pubmed_authors>Li L</pubmed_authors><pubmed_authors>Knisbacher BA</pubmed_authors><pubmed_authors>Redd R</pubmed_authors><pubmed_authors>Brown JR</pubmed_authors><pubmed_authors>Fell G</pubmed_authors><pubmed_authors>Neuberg D</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Wu CJ</pubmed_authors><pubmed_authors>Martinez A</pubmed_authors><pubmed_authors>Danysh BP</pubmed_authors><pubmed_authors>Rhrissorrakrai K</pubmed_authors><pubmed_authors>Kay NE</pubmed_authors><pubmed_authors>Utro F</pubmed_authors><pubmed_authors>Davids MS</pubmed_authors><pubmed_authors>Getz G</pubmed_authors><pubmed_authors>Leshchiner I</pubmed_authors><pubmed_authors>Jacobs R</pubmed_authors><pubmed_authors>Hergalant S</pubmed_authors><pubmed_authors>Wierda W</pubmed_authors><pubmed_authors>Schneider C</pubmed_authors><pubmed_authors>Rassenti LZ</pubmed_authors><pubmed_authors>Johnson C</pubmed_authors><pubmed_authors>Parry EM</pubmed_authors><pubmed_authors>Fernandes SM</pubmed_authors><pubmed_authors>Guieze R</pubmed_authors><pubmed_authors>Yin S</pubmed_authors><pubmed_authors>Parida L</pubmed_authors><pubmed_authors>Lemvigh C</pubmed_authors><pubmed_authors>Huang T</pubmed_authors><pubmed_authors>Feugier P</pubmed_authors><pubmed_authors>Persaud B</pubmed_authors><pubmed_authors>Taylor-Weiner A</pubmed_authors><pubmed_authors>Messer C</pubmed_authors><pubmed_authors>Ma J</pubmed_authors><pubmed_authors>Tausch E</pubmed_authors><pubmed_authors>Stilgenbauer S</pubmed_authors><pubmed_authors>Anandappa AJ</pubmed_authors><pubmed_authors>Rosebrock D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.</name><description>Richter syndrome (RS) arising from chronic lymphocytic leukemia (CLL) exemplifies an aggressive malignancy that develops from an indolent neoplasm. To decipher the genetics underlying this transformation, we computationally deconvoluted admixtures of CLL and RS cells from 52 patients with RS, evaluating paired CLL-RS whole-exome sequencing data. We discovered RS-specific somatic driver mutations (including IRF2BP2, SRSF1, B2M, DNMT3A and CCND3), recurrent copy-number alterations beyond del(9p21)(CDKN2A/B), whole-genome duplication and chromothripsis, which were confirmed in 45 independent RS cases and in an external set of RS whole genomes. Through unsupervised clustering, clonally related RS was largely distinct from diffuse large B cell lymphoma. We distinguished pathways that were dysre</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-28T12:22:25.789Z</modification><creation>2025-04-07T10:25:11.309Z</creation></dates><accession>S-EPMC10155825</accession><cross_references><pubmed>36624313</pubmed><doi>10.1038/s41591-022-02113-6</doi></cross_references></HashMap>